Kaposi's sarcoma.

Charting latency transcripts in Kaposi's sarcoma-associated herpesvirus by whole-genome real-time quantitative PCR. J Virol (2002) 2.71

Valganciclovir for suppression of human herpesvirus-8 replication: a randomized, double-blind, placebo-controlled, crossover trial. J Infect Dis (2008) 2.31

Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) infection of human fibroblast cells occurs through endocytosis. J Virol (2003) 2.04

Kaposi's sarcoma-associated herpesvirus induces the phosphatidylinositol 3-kinase-PKC-zeta-MEK-ERK signaling pathway in target cells early during infection: implications for infectivity. J Virol (2003) 1.97

ERK1/2 and MEK1/2 induced by Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) early during infection of target cells are essential for expression of viral genes and for establishment of infection. J Virol (2005) 1.95

Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 envelope glycoprotein gB induces the integrin-dependent focal adhesion kinase-Src-phosphatidylinositol 3-kinase-rho GTPase signal pathways and cytoskeletal rearrangements. J Virol (2004) 1.91

Spectrum of Kaposi's sarcoma-associated herpesvirus, or human herpesvirus 8, diseases. Clin Microbiol Rev (2002) 1.67

Kaposi's sarcoma-associated herpesvirus modulates microtubule dynamics via RhoA-GTP-diaphanous 2 signaling and utilizes the dynein motors to deliver its DNA to the nucleus. J Virol (2005) 1.64

Human herpesvirus 8 envelope glycoprotein B mediates cell adhesion via its RGD sequence. J Virol (2003) 1.53

Kaposi's sarcoma-associated herpesvirus utilizes an actin polymerization-dependent macropinocytic pathway to enter human dermal microvascular endothelial and human umbilical vein endothelial cells. J Virol (2009) 1.46

KSHV/HHV-8 infection of human hematopoietic progenitor (CD34+) cells: persistence of infection during hematopoiesis in vitro and in vivo. Blood (2006) 1.37

Integrin alphaVbeta3 Binds to the RGD motif of glycoprotein B of Kaposi's sarcoma-associated herpesvirus and functions as an RGD-dependent entry receptor. J Virol (2007) 1.33

Kaposi's sarcoma-associated herpesvirus ori-Lyt-dependent DNA replication: involvement of host cellular factors. J Virol (2008) 1.28

Frequent and asymptomatic oropharyngeal shedding of human herpesvirus 8 among immunocompetent men. J Infect Dis (2006) 1.27

Tumor necrosis factor blockade and the risk of viral infection. Nat Rev Rheumatol (2010) 1.24

Skin cancers associated with HIV infection and solid-organ transplantation among elderly adults. Int J Cancer (2010) 1.22

Non-AIDS associated Kaposi's sarcoma: clinical features and treatment outcome. PLoS One (2011) 1.19

Kaposi's sarcoma-associated herpesvirus glycoprotein K8.1 is dispensable for virus entry. J Virol (2004) 1.13

Activation of Akt through gp130 receptor signaling is required for Kaposi's sarcoma-associated herpesvirus-induced lymphatic reprogramming of endothelial cells. J Virol (2008) 1.12

Tumorigenesis induced by the HHV8-encoded chemokine receptor requires ligand modulation of high constitutive activity. J Clin Invest (2001) 1.12

Clinical uses of interferons. Br J Clin Pharmacol (2007) 1.11

Pulmonary involvement in Kaposi sarcoma: correlation between imaging and pathology. Orphanet J Rare Dis (2009) 1.09

Molecular biology of Kaposi's sarcoma-associated herpesvirus and related oncogenesis. Adv Virus Res (2010) 1.09

Activity of subcutaneous interleukin-12 in AIDS-related Kaposi sarcoma. Blood (2006) 1.08

New approaches to the treatment of human herpesvirus 8-associated disease. Rev Med Virol (2008) 1.07

Transcriptional regulation of the K1 gene product of Kaposi's sarcoma-associated herpesvirus. J Virol (2002) 1.05

The HIV protease inhibitor nelfinavir inhibits Kaposi's sarcoma-associated herpesvirus replication in vitro. Antimicrob Agents Chemother (2011) 1.03

CD8+ T cell dysfunction and increase in murine gammaherpesvirus latent viral burden in the absence of 4-1BB ligand. J Immunol (2007) 1.01

Human herpesvirus 8--a novel human pathogen. Virol J (2005) 1.00

Humanized-BLT mouse model of Kaposi's sarcoma-associated herpesvirus infection. Proc Natl Acad Sci U S A (2014) 1.00

KSHV: pathways to tumorigenesis and persistent infection. Adv Virus Res (2014) 0.99

Kaposi Sarcoma of Childhood: Inborn or Acquired Immunodeficiency to Oncogenic HHV-8. Pediatr Blood Cancer (2015) 0.99

A challenging case of rapid progressive Kaposi sarcoma after renal transplantation: diagnostics by FDG PET/CT. Medicine (Baltimore) (2014) 0.99

Classic Kaposi sarcoma in 3 unrelated Turkish children born to consanguineous kindreds. Pediatrics (2010) 0.99

Kaposi sarcoma involving the gastrointestinal tract. Gastroenterol Hepatol (N Y) (2010) 0.98

Kaposi's sarcoma in a child with Wiskott-Aldrich syndrome. Eur J Pediatr (2006) 0.96

Role of protein kinase C delta in reactivation of Kaposi's sarcoma-associated herpesvirus. J Virol (2004) 0.96

Risk factors for Kaposi's sarcoma among HIV-positive individuals in a case control study in Cameroon. Cancer Epidemiol (2014) 0.95

An update on nonmelanoma skin cancer. J Clin Aesthet Dermatol (2011) 0.95

Characterization of a peptide domain within the GB virus C NS5A phosphoprotein that inhibits HIV replication. PLoS One (2008) 0.93

Lytic and latent antigens of the human gammaherpesviruses Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus induce T-cell responses with similar functional properties and memory phenotypes. J Virol (2007) 0.92

Tegument Proteins of Kaposi's Sarcoma-Associated Herpesvirus and Related Gamma-Herpesviruses. Front Microbiol (2012) 0.92

Dermatomyositis complicated with Kaposi sarcoma: a case report. Clin Rheumatol (2006) 0.92

Novel Kaposi's sarcoma-associated herpesvirus homolog in baboons. J Virol (2003) 0.91

Peripheral blood endothelial progenitors as potential reservoirs of Kaposi's sarcoma-associated herpesvirus. PLoS One (2008) 0.90

Kaposi's sarcoma-associated herpesvirus inhibits interleukin-4-mediated STAT6 phosphorylation to regulate apoptosis and maintain latency. J Virol (2010) 0.90

Immunohistochemical detection of the latent nuclear antigen-1 of the human herpesvirus type 8 to differentiate cutaneous epidemic Kaposi sarcoma and its histological simulators. An Bras Dermatol (2013) 0.90

Evidence for both lytic replication and tightly regulated human herpesvirus 8 latency in circulating mononuclear cells, with virus loads frequently below common thresholds of detection. J Virol (2004) 0.90

Head and neck soft tissue sarcoma. Indian J Surg Oncol (2012) 0.90

Human herpesvirus-8 in northwestern China: epidemiology and characterization among blood donors. Virol J (2010) 0.89

Human herpesvirus-8 and other viral infections, Papua New Guinea. Emerg Infect Dis (2001) 0.89

Iatrogenic colorectal Kaposi sarcoma complicating a refractory ulcerative colitis in a human immunodeficiency negative-virus patient. Pan Afr Med J (2013) 0.89

Kaposi's sarcoma after liver transplantation. J Cancer Res Clin Oncol (2007) 0.88

Kaposi's sarcoma-associated herpesvirus infection of endothelial cells inhibits neutrophil recruitment through an interleukin-6-dependent mechanism: a new paradigm for viral immune evasion. J Virol (2011) 0.88

Endothelin receptor blockade inhibits molecular effectors of Kaposi's sarcoma cell invasion and tumor growth in vivo. Am J Pathol (2003) 0.88

Next-generation sequence analysis of the genome of RFHVMn, the macaque homolog of Kaposi's sarcoma (KS)-associated herpesvirus, from a KS-like tumor of a pig-tailed macaque. J Virol (2013) 0.87

The KSHV viral IL-6 homolog is sufficient to induce blood to lymphatic endothelial cell differentiation. Virology (2012) 0.86

Development of a fluorescence-based assay to screen antiviral drugs against Kaposi's sarcoma associated herpesvirus. Mol Cancer Ther (2007) 0.86

Kaposi's sarcoma-associated herpesvirus glycoproteins B and K8.1 regulate virion egress and synthesis of vascular endothelial growth factor and viral interleukin-6 in BCBL-1 cells. J Virol (2009) 0.85

Iron: a target for the management of Kaposi's sarcoma? BMC Cancer (2004) 0.85

Current knowledge of MicroRNAs and noncoding RNAs in virus-infected cells. Methods Mol Biol (2010) 0.84

Conservation of complex nuclear localization signals utilizing classical and non-classical nuclear import pathways in LANA homologs of KSHV and RFHV. PLoS One (2011) 0.84

Kaposi's sarcoma associated herpesvirus G-protein coupled receptor activation of cyclooxygenase-2 in vascular endothelial cells. Virol J (2007) 0.84

Multitarget, quantitative nanoplasmonic electrical field-enhanced resonating device (NE2RD) for diagnostics. Proc Natl Acad Sci U S A (2015) 0.84

Potent antiviral activity of topoisomerase I and II inhibitors against Kaposi's sarcoma-associated herpesvirus. Antimicrob Agents Chemother (2011) 0.83

The ORF59 DNA polymerase processivity factor homologs of Old World primate RV2 rhadinoviruses are highly conserved nuclear antigens expressed in differentiated epithelium in infected macaques. Virol J (2009) 0.82

Comparative evaluation of three serological methods for detection of human herpesvirus 8-specific antibodies in Canadian allogeneic stem cell transplant recipients. J Clin Microbiol (2004) 0.82

Kaposi's sarcoma associated with previous human herpesvirus 8 infection in heart transplant recipients. J Clin Microbiol (2002) 0.82

Classic Kaposi Sarcoma: to treat or not to treat? BMC Res Notes (2015) 0.82

Herpesvirus infections of the central nervous system in immunocompromised patients. Ther Adv Neurol Disord (2012) 0.81

Characterization of human herpes virus 8 genotypes in Kaposi's sarcoma patients in Tehran, Iran. Int J Mol Epidemiol Genet (2012) 0.81

Human herpesvirus-8 infection leads to expansion of the preimmune/natural effector B cell compartment. PLoS One (2010) 0.81

Overexpression of xCT induces up-regulation of 14-3-3beta in Kaposi's sarcoma. Biosci Rep (2010) 0.81

Epidemiology of classic Kaposi's sarcoma in the Israeli Jewish population between 1960 and 1998. Br J Cancer (2003) 0.81

Localization of human herpesvirus type 8 in human sperms by in situ PCR. J Mol Histol (2006) 0.81

The cytoplasmic terminus of Kaposi's sarcoma-associated herpesvirus glycoprotein B is not essential for virion egress and infectivity. J Virol (2008) 0.80

Treatment with valacyclovir, famciclovir, or antiretrovirals reduces human herpesvirus-8 replication in HIV-1 seropositive men. J Med Virol (2011) 0.80

Radiotherapy in the management of Kaposi's sarcoma: comparison of 8 Gy versus 6 Gy. J Natl Med Assoc (2006) 0.80

Cancers associated with Kaposi's sarcoma (KS) in AIDS: a link between KS herpesvirus and immunoblastic lymphoma. Br J Cancer (2001) 0.80

Gastrointestinal Kaposi's sarcoma: Case report and review of the literature. World J Gastrointest Pharmacol Ther (2015) 0.80

VP22 core domain from Herpes simplex virus 1 reveals a surprising structural conservation in both the Alpha- and Gammaherpesvirinae subfamilies. J Gen Virol (2015) 0.80

Antiviral activity of (+)-rutamarin against Kaposi's sarcoma-associated herpesvirus by inhibition of the catalytic activity of human topoisomerase II. Antimicrob Agents Chemother (2013) 0.79

Pathology of Kaposi's Sarcoma-Associated Herpesvirus Infection. Front Microbiol (2011) 0.79

Kaposi sarcoma in calabar, southern Nigeria. Oman Med J (2009) 0.79

Printed Flexible Plastic Microchip for Viral Load Measurement through Quantitative Detection of Viruses in Plasma and Saliva. Sci Rep (2015) 0.79

Disseminated Kaposi sarcoma in a HIV negative patient. Int J Clin Exp Pathol (2015) 0.79

Celecoxib Inhibits the Lytic Activation of Kaposi's Sarcoma-Associated Herpesvirus through Down-Regulation of RTA Expression by Inhibiting the Activation of p38 MAPK. Viruses (2015) 0.79

Disseminated Kaposi's sarcoma without cutaneous involvement. Proc (Bayl Univ Med Cent) (2014) 0.77

Genotypic analysis of Kaposi's sarcoma-associated herpesvirus from patients with Kaposi's sarcoma in Xinjiang, China. Viruses (2014) 0.77

Kaposi's sarcoma-associated herpesvirus-encoded LANA down-regulates IL-22R1 expression through a cis-acting element within the promoter region. PLoS One (2011) 0.77

Oral HHV-8 replication among women in Mombasa, Kenya. J Med Virol (2014) 0.77

Ets-1 is required for the activation of VEGFR3 during latent Kaposi's sarcoma-associated herpesvirus infection of endothelial cells. J Virol (2013) 0.77

Human herpesviruses 6, 7, and 8 from a dermatologic perspective. Mayo Clin Proc (2012) 0.77

High seroprevalence of antibodies against Kaposi's sarcoma-associated herpesvirus (KSHV) among HIV-1-infected children and adolescents in a non-endemic population. Med Microbiol Immunol (2016) 0.77

Kaposi sarcoma-associated herpesvirus g protein-coupled receptor enhances endothelial cell survival in part by upregulation of bcl-2. Ochsner J (2013) 0.77

Model-based inference of recombination hotspots in a highly variable oncogene [corrected]. J Mol Evol (2004) 0.77

Molecularly targeted therapy for Kaposi's sarcoma in a kidney transplant patient: case report, "what worked and what did not". BMC Nephrol (2007) 0.77

A Review of Human Herpesvirus 8, the Kaposi's Sarcoma-Associated Herpesvirus, in the Pediatric Population. J Pediatric Infect Dis Soc (2013) 0.77

Role of radiotherapy in local control of non-AIDS associated Kaposi's sarcoma patients in Korea: a single institution experience. Radiat Oncol J (2012) 0.77

Disseminated cutaneous and visceral Kaposi sarcoma in a woman with rheumatoid arthritis receiving leflunomide. Rheumatol Int (2010) 0.77

Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA (2001) 24.12

Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med (1991) 23.89

Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med (1995) 21.16

Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). Proc Natl Acad Sci U S A (1996) 12.89

Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and without HIV infection. N Engl J Med (1995) 8.52

In vitro establishment and characterization of two acquired immunodeficiency syndrome-related lymphoma cell lines (BC-1 and BC-2) containing Kaposi's sarcoma-associated herpesvirus-like (KSHV) DNA sequences. Blood (1995) 6.91

Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV. Science (1996) 6.57

Vitamin D levels and early mortality among incident hemodialysis patients. Kidney Int (2007) 6.35

KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma. Nat Med (1996) 5.96

Primary characterization of a herpesvirus agent associated with Kaposi's sarcomae. J Virol (1996) 5.05

Transcription mapping of the Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) genome in a body cavity-based lymphoma cell line (BC-1). J Virol (1998) 4.62

Ten-year experience with 733 pancreatic resections: changing indications, older patients, and decreasing length of hospitalization. Arch Surg (2001) 4.59

Effect of economic reforms on child growth in urban and rural areas of China. N Engl J Med (1996) 4.50

Selective switch between latency and lytic replication of Kaposi's sarcoma herpesvirus and Epstein-Barr virus in dually infected body cavity lymphoma cells. J Virol (1997) 4.45

Seroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma. N Engl J Med (1996) 4.13

The effect of enforcing tobacco-sales laws on adolescents' access to tobacco and smoking behavior. N Engl J Med (1997) 4.06

Angiogenic and HIV-inhibitory functions of KSHV-encoded chemokines. Science (1997) 3.70

Antibodies to butyrate-inducible antigens of Kaposi's sarcoma-associated herpesvirus in patients with HIV-1 infection. N Engl J Med (1996) 3.61

Kaposi's sarcoma-associated herpesvirus contains G protein-coupled receptor and cyclin D homologs which are expressed in Kaposi's sarcoma and malignant lymphoma. J Virol (1996) 3.48

Cyclin encoded by KS herpesvirus. Nature (1996) 3.32

Benign prostatic hyperplasia specific health status measures in clinical research: how much change in the American Urological Association symptom index and the benign prostatic hyperplasia impact index is perceptible to patients? J Urol (1995) 3.15

Vibrio cholerae hemagglutinin/protease, colonial variation, virulence, and detachment. Infect Immun (1992) 2.80

Impaired host defense, hematopoiesis, granulomatous inflammation and type 1-type 2 cytokine balance in mice lacking CC chemokine receptor 1. J Exp Med (1997) 2.79

Delayed posthypoxic demyelination. Association with arylsulfatase A deficiency and lactic acidosis on proton MR spectroscopy. Neurology (1997) 2.66

Angiogenesis and hematopoiesis induced by Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6. Blood (1999) 2.65

Toward an optimal algorithm for ovarian cancer screening with longitudinal tumor markers. Cancer (1995) 2.64

Kaposi's sarcoma-associated herpesvirus encodes a functional bcl-2 homologue. Nat Med (1997) 2.64

KSHV ORF K9 (vIRF) is an oncogene which inhibits the interferon signaling pathway. Oncogene (1997) 2.57

Differential viral protein expression in Kaposi's sarcoma-associated herpesvirus-infected diseases: Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease. Am J Pathol (2000) 2.55

Processes of care, illness severity, and outcomes in the management of community-acquired pneumonia at academic hospitals. Arch Intern Med (2001) 2.51

Kaposi's sarcoma-associated herpesvirus infection prior to onset of Kaposi's sarcoma. AIDS (1996) 2.49

Characterization and cell cycle regulation of the major Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) latent genes and their promoter. J Virol (1999) 2.41

Association of genetic variation in FTO with risk of obesity and type 2 diabetes with data from 96,551 East and South Asians. Diabetologia (2011) 2.37

Leaving gatekeeping behind--effects of opening access to specialists for adults in a health maintenance organization. N Engl J Med (2001) 2.29

The cyclin encoded by Kaposi's sarcoma-associated herpesvirus stimulates cdk6 to phosphorylate the retinoblastoma protein and histone H1. J Virol (1997) 2.24

Helicobacter pylori infection in intestinal- and diffuse-type gastric adenocarcinomas. J Natl Cancer Inst (1991) 2.23

Kaposi's sarcoma-associated herpesvirus LANA2 is a B-cell-specific latent viral protein that inhibits p53. J Virol (2001) 2.21

Surgical and nonsurgical management of sciatica secondary to a lumbar disc herniation: five-year outcomes from the Maine Lumbar Spine Study. Spine (Phila Pa 1976) (2001) 2.17

Implications of stroke risk criteria on the anticoagulation decision in nonvalvular atrial fibrillation: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study. Circulation (2000) 2.09

The impact of choice of muscle relaxant on postoperative recovery time: a retrospective study. Anesth Analg (1997) 2.03

A Kaposi's sarcoma-associated herpesvirus-encoded cytokine homolog (vIL-6) activates signaling through the shared gp130 receptor subunit. J Biol Chem (1997) 2.00

Long-term disability and return to work among patients who have a herniated lumbar disc: the effect of disability compensation. J Bone Joint Surg Am (2000) 1.95

Establishing a KSHV+ cell line (BCP-1) from peripheral blood and characterizing its growth in Nod/SCID mice. Blood (1998) 1.95

Involvement of interleukin-10 (IL-10) and viral IL-6 in the spontaneous growth of Kaposi's sarcoma herpesvirus-associated infected primary effusion lymphoma cells. Blood (1999) 1.84

MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo. Oncogene (2011) 1.81

Prevention of heterosexual transmission of human immunodeficiency virus through couple counseling. J Acquir Immune Defic Syndr (1993) 1.79

Outcome of pancreaticoduodenectomy with pylorus preservation or with antrectomy in the treatment of chronic pancreatitis. Ann Surg (2000) 1.76

Expression of a virus-derived cytokine, KSHV vIL-6, in HIV-seronegative Castleman's disease. Am J Pathol (1997) 1.72

Short-acting nifedipine and risk of stroke in elderly hypertensive patients. Neurology (2011) 1.70

Molecular virology of Kaposi's sarcoma-associated herpesvirus. Philos Trans R Soc Lond B Biol Sci (2001) 1.65

Antitumor activity of sorafenib in FLT3-driven leukemic cells. Leukemia (2007) 1.65

Establishment of AIDS-related lymphoma cell lines from lymphomatous effusions. Leukemia (1996) 1.63

Test-retest reliability of a functional MRI working memory paradigm in normal and schizophrenic subjects. Am J Psychiatry (2001) 1.59

Safely increasing the proportion of patients with community-acquired pneumonia treated as outpatients: an interventional trial. Arch Intern Med (1998) 1.55

308-nm excimer laser for the treatment of psoriasis: a dose-response study. Arch Dermatol (2000) 1.54

Retracted Three unrelated viral transforming proteins (vIRF, EBNA2, and E1A) induce the MYC oncogene through the interferon-responsive PRF element by using different transcription coadaptors. Proc Natl Acad Sci U S A (1999) 1.52

Utility of perfusion-weighted CT imaging in acute middle cerebral artery stroke treated with intra-arterial thrombolysis: prediction of final infarct volume and clinical outcome. Stroke (2001) 1.52

Topical ALA-photodynamic therapy for the treatment of acne vulgaris. J Invest Dermatol (2000) 1.50

Ultrasonography by emergency physicians in patients with suspected cholecystitis. Am J Emerg Med (2001) 1.50

Posttransplantation plasmacytic proliferations related to Kaposi's sarcoma-associated herpesvirus. Am J Surg Pathol (1999) 1.49

Nasopharyngeal swab and PCR for the screening of nasopharyngeal carcinoma in the endemic area: a good supplement to the serologic screening. Head Neck (1998) 1.47

Evidence for the exchange of segments between genomes during the evolution of lambdoid bacteriophages. Mol Microbiol (1990) 1.44

Increasing Kaposi's sarcoma-associated herpesvirus seroprevalence with age in a highly Kaposi's sarcoma endemic region, Zambia in 1985. AIDS (1998) 1.40

Prevalence of antineutrophil cytoplasmic antibodies in a large inception cohort of patients with connective tissue disease. Ann Intern Med (1997) 1.40

Anomalous origin of one pulmonary artery from the innominate artery: a report of two cases. Pediatr Cardiol (2001) 1.40

Treatment of murine lupus with cDNA encoding IFN-gammaR/Fc. J Clin Invest (2000) 1.40

Cell cycle arrest induced by an inhibitor of glucosylceramide synthase. Correlation with cyclin-dependent kinases. J Biol Chem (1995) 1.39

Combined functional magnetic resonance imaging and transcranial magnetic stimulation evidence of ipsilateral motor pathway with congenital brain disorder: a case report. Arch Phys Med Rehabil (2001) 1.39

KSHV-encoded CC chemokine vMIP-III is a CCR4 agonist, stimulates angiogenesis, and selectively chemoattracts TH2 cells. Blood (2000) 1.39

Metabolic detriment in donor heart valves induced by ischemia and cryopreservation. Ann Thorac Surg (1998) 1.38

The prevalence and clinical associations of anticardiolipin antibodies in a large inception cohort of patients with connective tissue diseases. Am J Med (1996) 1.38

A unique 33-kD cysteine proteinase accumulates in response to larval feeding in maize genotypes resistant to fall armyworm and other Lepidoptera. Plant Cell (2000) 1.33

Regulation of HIV expression: mechanisms of action of Tat and Rev. AIDS (1991) 1.31

Proteoglycans synthesized by smooth muscle cells derived from monkey (Macaca nemestrina) aorta. J Biol Chem (1983) 1.31

KSHV-encoded viral IL-6 activates multiple human IL-6 signaling pathways. Hum Immunol (1999) 1.30

HHV8 and skin cancers in immunosuppressed patients. Lancet (1996) 1.29

Manganese exposure and cognitive deficits: a growing concern for manganese neurotoxicity. Neurotoxicology (2012) 1.27

Kaposi's sarcoma-associated herpesvirus: a new DNA tumor virus. Annu Rev Med (2001) 1.27

Kaposi's sarcoma (KS), KS-associated herpesvirus, and the criteria for causality in the age of molecular biology. Am J Epidemiol (1998) 1.26

Switching to gatekeeping: changes in expenditures and utilization for children. Pediatrics (2001) 1.26

Distribution of medical insurance in China. Soc Sci Med (1995) 1.23

Endometrial cancer in women 40 years old or younger. Gynecol Oncol (2001) 1.20

Antiviral activity of tumor-suppressor pathways: clues from molecular piracy by KSHV. Trends Genet (1998) 1.20

Role for telemedicine in acute stroke. Feasibility and reliability of remote administration of the NIH stroke scale. Stroke (1999) 1.19

Down-regulation of vascular endothelial growth factor by tissue inhibitor of metalloproteinase-2: effect on in vivo mammary tumor growth and angiogenesis. Cancer Res (2001) 1.18

Crosslinking characteristics and mechanical properties of a bovine pericardium fixed with a naturally occurring crosslinking agent. J Biomed Mater Res (1999) 1.18

Sensitivity and specificity of NMP-22, telomerase, and BTA in the detection of human bladder cancer. Urology (1998) 1.17

HYP1, a hydrophobin gene from Aspergillus fumigatus, complements the rodletless phenotype in Aspergillus nidulans. Infect Immun (1994) 1.16

Methotrexate used in combination with aminolaevulinic acid for photodynamic killing of prostate cancer cells. Br J Cancer (2006) 1.16

Clinical-grade functional dendritic cells from patients with multiple myeloma are not infected with Kaposi's sarcoma-associated herpesvirus. Blood (1998) 1.16

Profile of cytokine expression in nasopharyngeal carcinomas: a distinct expression of interleukin 1 in tumor and CD4+ T cells. Cancer Res (1999) 1.15

Kaposi's sarcoma-associated herpesvirus-encoded oncogenes and oncogenesis. J Natl Cancer Inst Monogr (1998) 1.11

Fixation of biological tissues with a naturally occurring crosslinking agent: fixation rate and effects of pH, temperature, and initial fixative concentration. J Biomed Mater Res (2000) 1.11

Molecular cloning of new human TR2 receptors: a class of steroid receptor with multiple ligand-binding domains. Biochem Biophys Res Commun (1989) 1.10

Suitability of human juvenile pancreatic islets for clinical use. Diabetologia (2006) 1.09

Ultrasonography by emergency physicians in patients with suspected ureteral colic. J Emerg Med (1999) 1.08

Hrs-2 regulates receptor-mediated endocytosis via interactions with Eps15. J Biol Chem (2000) 1.08

Effects of commonly consumed vegetables on hepatic xenobiotic-metabolizing enzymes in the mouse. Food Chem Toxicol (1985) 1.07

TGF-beta1 somatic gene therapy prevents autoimmune disease in nonobese diabetic mice. J Immunol (1998) 1.06

Permeability and single channel conductance of human homomeric rho1 GABAC receptors. J Physiol (1999) 1.06